Pharvaris N.V.
PHVS
$32.94
$1.695.41%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 51.26M | 50.40M | 52.21M | 52.17M | 50.95M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 192.00M | 184.65M | 179.95M | 171.14M | 157.48M |
| Operating Income | -192.00M | -184.65M | -179.95M | -171.14M | -157.48M |
| Income Before Tax | -195.94M | -179.20M | -181.17M | -161.71M | -143.37M |
| Income Tax Expenses | 2.27M | 1.66M | 2.12M | 1.97M | 1.96M |
| Earnings from Continuing Operations | -198.21 | -180.86 | -183.29 | -163.68 | -145.33 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -198.21M | -180.86M | -183.29M | -163.68M | -145.33M |
| EBIT | -192.00M | -184.65M | -179.95M | -171.14M | -157.48M |
| EBITDA | -191.78M | -184.46M | -179.76M | -170.93M | -157.24M |
| EPS Basic | -3.37 | -3.22 | -3.37 | -3.02 | -2.69 |
| Normalized Basic EPS | -2.08 | -1.99 | -2.08 | -1.86 | -1.66 |
| EPS Diluted | -3.37 | -3.22 | -3.37 | -3.02 | -2.69 |
| Normalized Diluted EPS | -2.08 | -1.99 | -2.08 | -1.86 | -1.66 |
| Average Basic Shares Outstanding | 236.55M | 225.75M | 217.57M | 216.82M | 216.08M |
| Average Diluted Shares Outstanding | 236.55M | 225.75M | 217.57M | 216.82M | 216.08M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |